3results about How to "Avoid treatment" patented technology

The utility model relates to the technical field of droppers, in particular to a disposable dropper with a filtering function, which comprises a hose body with a solution cavity, the bottom of the hose body is provided with a first opening communicated with the solution cavity, the first opening is detachably provided with a filtering dropping head, and the filtering dropping head is provided with a dropping channel penetrating through the upper surface and the lower surface of the filtering dropping head. And a filtering sponge and a filtering membrane are sequentially arranged on the liquid dropping channel along the liquid outlet direction. Compared with the prior art, the filter sponge and the filter membrane are sequentially arranged in the filter channel along the liquid outlet direction; a diluent in the solution cavity can firstly pass through the filtering sponge to filter secretions in a sample, so that the clarity of the diluent inoculated to a drug sensitive culture medium is ensured; in addition, infectious microbes can be filtered through the filter membrane, it is guaranteed that diluent inoculated to the drug sensitive culture medium does not contain impurities and infectious microbes, the test reliability and accuracy of the drug sensitive culture medium are improved, and the situation that doctors are misguided to take drugs and patients are misguided to treat the drugs is eradicated.

This application relates to the field of biomedicine, specifically to the use of small molecule compounds in the preparation of drugs for the treatment and / or prevention of α-synuclein diseases, wherein the small molecule compounds are selected from at least one of AO-365 / 43264238 and AG-670 / 40728295. The small molecule compounds provided in this invention can precisely target and interfere with α-syn-VAPB interactions, improving neuronal damage caused by abnormal aggregation of α-synuclein, thereby safely and effectively treating and / or preventing α-synuclein diseases, particularly Parkinson's disease.